Yahoo · Aug 7, 2026
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Smart Beta ETF report for XPH
XP
AMEX · XPH
SPDR S&P Pharmaceuticals ETF
Financial Services · Asset Management
$73.57
Up+$0.89 (+1.22%)
Updated Aug 26, 2026, 2:07 AM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 207.79M
- P/E ratio
- —
- Dividend yield
- 0.69%
- 52-week range
- $45.80 – $74.35
- Volume
- 97.32K
- Avg. volume
- 56.55K
Price performance
XPH price history
1M range · 21 trading sessions · Daily adjusted prices
XPH closed at $73.57 after 21 trading sessions, up 6.62% for the selected period.
- Last close
- $73.57
- Period change
- +6.62%
- Period low
- $68.06
- Period high
- $74.06
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | $73.06 | $73.63 | $73.06 | $73.57 | 97.32K |
| Aug 24, 2026 | $72.60 | $72.82 | $71.60 | $72.68 | 110.3K |
| Aug 21, 2026 | $72.84 | $73.3499 | $72.68 | $72.80 | 83.8K |
| Aug 20, 2026 | $73.42 | $73.674 | $72.10 | $72.29 | 158.74K |
| Aug 19, 2026 | $73.50 | $74.345 | $73.38 | $74.06 | 134.88K |
| Aug 18, 2026 | $71.10 | $72.485 | $71.0551 | $72.45 | 122.88K |
| Aug 17, 2026 | $70.03 | $70.725 | $69.66 | $70.42 | 86.9K |
| Aug 14, 2026 | $69.96 | $71.00 | $69.50 | $70.98 | 131.17K |
| Aug 13, 2026 | $70.67 | $71.11 | $69.89 | $69.98 | 134.22K |
| Aug 12, 2026 | $70.08 | $70.24 | $69.56 | $69.81 | 77.74K |
| Aug 11, 2026 | $70.32 | $70.5135 | $69.50 | $69.74 | 115.52K |
| Aug 10, 2026 | $70.43 | $70.78 | $69.71 | $70.11 | 93.28K |
| Aug 7, 2026 | $70.97 | $71.04 | $69.86 | $70.52 | 113.23K |
| Aug 6, 2026 | $69.95 | $70.69 | $69.79 | $70.34 | 50.56K |
| Aug 5, 2026 | $70.42 | $71.13 | $69.60 | $70.02 | 110.81K |
| Aug 4, 2026 | $68.72 | $69.80 | $68.515 | $69.80 | 168.51K |
| Aug 3, 2026 | $68.40 | $68.40 | $66.895 | $68.23 | 224.24K |
| Jul 31, 2026 | $69.10 | $69.10 | $67.1429 | $68.06 | 67.56K |
| Jul 30, 2026 | $68.61 | $69.93 | $68.555 | $69.74 | 54.25K |
| Jul 29, 2026 | $68.92 | $69.6272 | $68.34 | $68.70 | 123.69K |
| Jul 28, 2026 | $68.98 | $69.11 | $68.23 | $69.00 | 66.88K |
Latest XPH news
The latest Smart Investors Daily articles mentioning XPH.
Stock researchCompany · Overview
XPH research
Overview
Company profile and research snapshot.
Company profile
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Aug 6, 2026
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Sector ETF report for XPH
SeekingAlpha · Jul 30, 2026
Some More Notes On Pharmaceutical Tariffs
With yet another announcement on pharmaceutical tariffs last week, Diederik Stadig takes stock of where we stand on pharmaceutical tariffs. Read more here.
Benzinga · Jul 24, 2026
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
